Physician profile
Jeffrey Geller
NPI 1083650758
$586,308.32
in general payments reported to CMS, 2019-2025
13 companies · $154K in 2025
The $154K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77K · 2020: $23K · 2021: $28K · 2022: $107K · 2023: $91K · 2024: $106K · 2025: $154K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $258K · Consulting Fee: $42K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Travel and Lodging: $7,694 · Food and Beverage: $4,690 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $258,267.01 |
| Consulting Fee | $42,387.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,882.50 |
| Travel and Lodging | $7,694.02 |
| Food and Beverage | $4,690.10 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $581,722.18 | 2019-2025 | Journey II, Real Intelligence, K-15 Pork |
| Zimmer Biomet Holdings, INC. | $2,652.77 | 2019-2025 | Oxford, Avenir, Rosa |
| Stryker Corporation | $682.56 | 2019-2024 | Mako |
| Depuy Synthes Sales INC. | $474.72 | 2020-2024 | Actis, Emphasys, Tfn-Advance |
| Medacta USA, INC. | $152.09 | 2025 | Amistem, Gmk Sphere |
| Heron Therapeutics, INC. | $135.31 | 2025 | Zynrelef |
| Kci USA, INC. | $125.05 | 2019-2023 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Guard Medical INC. | $124.14 | 2025 | Npseal |
| Innovation Technologies INC | $120.40 | 2024 | Irrisept |
| Horizon Therapeutics Plc | $66.21 | 2019-2021 | |
| Ethicon US, LLC | $28.31 | 2024 | Stratafix |
| Vertex Pharmaceuticals Incorporated | $24.58 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Geller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.